biden glp-1 wanted Medicaid to pay for weight-loss drugs. Trump just said it doesn't have to. • Stateline Popular GLP-1 medications may have

Non-GLP-1 obesity drugs are emerging, with this landscape expected to surge 50-fold over the next five years, generating $15.5bn in 2031.

This specialized delivery system helps shield the active berberine molecules through the stomach, supporting up to 10X greater cellular uptake while remaining gentle on your digestive system

Recent FDA actions suggest that the "wild west" of large-scale production may be coming to an end

Learn the criteria for coverage and how to check whether you qualify for Zepbound coverage.

As GLP-1 medications like Ozempic gain popularity, reports of sagging skin and facial volume loss have also increased

Inphase 3 clinical trials (SURPASS 1-5), the dose-dependent efficacy and safety of tirzepatide were assessed by once-weekly subcutaneous injection (5mg, 10mg, and 15 mg), as monotherapy or combination therapy, in individuals with T2DM